Successful treatment of erythromelalgia with intrathecal hydromorphone and clonidine

Stephen M Macres, Steven Richeimer

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: The objective of this study was to determine if intractable pain from erythromelalgia could be successfully treated with intrathecal hydromorphone and clonidine. Design: A single case of pain from erythromelalgia refractory to multiple treatment modalities was examined and treated. Setting: The setting is an outpatient pain clinic at a major university teaching hospital. Patient: Our patient is an 82-year-old woman with hypertension and peripheral vascular disease. Intervention: Intrathecal opioid and an α2-agonist were administered. Outcome Measures: Outcome was determined by means of patient self-report during office follow-up visits. Results and Conclusions: Administration of intrathecal opioid and an α2-agonist can be effective in the treatment of the pain of erythromelalgia and offers an alternative pain treatment modality for patients with unremitting pain refractory to more conservative therapy.

Original languageEnglish (US)
Pages (from-to)310-313
Number of pages4
JournalClinical Journal of Pain
Volume16
Issue number4
DOIs
StatePublished - 2000

Fingerprint

Erythromelalgia
Hydromorphone
Clonidine
Intractable Pain
Opioid Analgesics
Pain Clinics
Pain
Peripheral Vascular Diseases
Therapeutics
Ambulatory Care Facilities
Teaching Hospitals
Self Report
Outcome Assessment (Health Care)
Hypertension

Keywords

  • Clonidine
  • Erythromelalgia
  • Intrathecal opioids

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology

Cite this

Successful treatment of erythromelalgia with intrathecal hydromorphone and clonidine. / Macres, Stephen M; Richeimer, Steven.

In: Clinical Journal of Pain, Vol. 16, No. 4, 2000, p. 310-313.

Research output: Contribution to journalArticle

@article{aca5ca1e55204e8d9a1f5d72aa6c40bf,
title = "Successful treatment of erythromelalgia with intrathecal hydromorphone and clonidine",
abstract = "Objective: The objective of this study was to determine if intractable pain from erythromelalgia could be successfully treated with intrathecal hydromorphone and clonidine. Design: A single case of pain from erythromelalgia refractory to multiple treatment modalities was examined and treated. Setting: The setting is an outpatient pain clinic at a major university teaching hospital. Patient: Our patient is an 82-year-old woman with hypertension and peripheral vascular disease. Intervention: Intrathecal opioid and an α2-agonist were administered. Outcome Measures: Outcome was determined by means of patient self-report during office follow-up visits. Results and Conclusions: Administration of intrathecal opioid and an α2-agonist can be effective in the treatment of the pain of erythromelalgia and offers an alternative pain treatment modality for patients with unremitting pain refractory to more conservative therapy.",
keywords = "Clonidine, Erythromelalgia, Intrathecal opioids",
author = "Macres, {Stephen M} and Steven Richeimer",
year = "2000",
doi = "10.1097/00002508-200012000-00006",
language = "English (US)",
volume = "16",
pages = "310--313",
journal = "Clinical Journal of Pain",
issn = "0749-8047",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Successful treatment of erythromelalgia with intrathecal hydromorphone and clonidine

AU - Macres, Stephen M

AU - Richeimer, Steven

PY - 2000

Y1 - 2000

N2 - Objective: The objective of this study was to determine if intractable pain from erythromelalgia could be successfully treated with intrathecal hydromorphone and clonidine. Design: A single case of pain from erythromelalgia refractory to multiple treatment modalities was examined and treated. Setting: The setting is an outpatient pain clinic at a major university teaching hospital. Patient: Our patient is an 82-year-old woman with hypertension and peripheral vascular disease. Intervention: Intrathecal opioid and an α2-agonist were administered. Outcome Measures: Outcome was determined by means of patient self-report during office follow-up visits. Results and Conclusions: Administration of intrathecal opioid and an α2-agonist can be effective in the treatment of the pain of erythromelalgia and offers an alternative pain treatment modality for patients with unremitting pain refractory to more conservative therapy.

AB - Objective: The objective of this study was to determine if intractable pain from erythromelalgia could be successfully treated with intrathecal hydromorphone and clonidine. Design: A single case of pain from erythromelalgia refractory to multiple treatment modalities was examined and treated. Setting: The setting is an outpatient pain clinic at a major university teaching hospital. Patient: Our patient is an 82-year-old woman with hypertension and peripheral vascular disease. Intervention: Intrathecal opioid and an α2-agonist were administered. Outcome Measures: Outcome was determined by means of patient self-report during office follow-up visits. Results and Conclusions: Administration of intrathecal opioid and an α2-agonist can be effective in the treatment of the pain of erythromelalgia and offers an alternative pain treatment modality for patients with unremitting pain refractory to more conservative therapy.

KW - Clonidine

KW - Erythromelalgia

KW - Intrathecal opioids

UR - http://www.scopus.com/inward/record.url?scp=0034520760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034520760&partnerID=8YFLogxK

U2 - 10.1097/00002508-200012000-00006

DO - 10.1097/00002508-200012000-00006

M3 - Article

C2 - 11153786

AN - SCOPUS:0034520760

VL - 16

SP - 310

EP - 313

JO - Clinical Journal of Pain

JF - Clinical Journal of Pain

SN - 0749-8047

IS - 4

ER -